ipratropium bromide and albuterol

FDA Drug Profile — Combivent Respimat

ipratropium bromide and albuterol is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Combivent Respimat. Available dosage form: spray, metered.

Drug details

Generic Name
ipratropium bromide and albuterol
Brand Names
Combivent Respimat
Application Number
NDA021747
Sponsor
Boehringer Ingelheim Pharmaceuticals, Inc.
NDC Codes
1
Dosage Forms
SPRAY, METERED
Routes
RESPIRATORY (INHALATION)
Active Ingredients
IPRATROPIUM BROMIDE, ALBUTEROL SULFATE

Indications and Usage

1 INDICATIONS AND USAGE COMBIVENT RESPIMAT is a combination of ipratropium bromide (an anticholinergic agent) and albuterol sulfate (a beta 2 -adrenergic agonist) indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator. COMBIVENT RESPIMAT Inhalation Spray is a combination of ipratropium bromide (an anticholinergic agent) and albuterol sulfate (a beta 2 ‑adrenergic agonist) indicated for: Patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator (1)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.